Stocks and Investing
Source: (remove) : marketindex
RSS • JSON • XML • CSV
Stocks and Investing
Source: (remove) : marketindex
RSS • JSON • XML • CSV

Should you buy the dip on ASX healthcare stocks CSL, Cochlear and Pro Medicus?


Published on 2025-02-17 23:01:10 - marketindex
  Print publication without navigation

  • CSL and Cochlear are two of Australia's blue-chip healthcare stocks, stalwarts of many investors portfolios, whereas Pro Medicus is likely either a relatively new addition, or is on many investors' shopping lists.

The article discusses the potential investment opportunities in ASX healthcare stocks, focusing on CSL, Cochlear, and Pro Medicus, following a dip in their stock prices. CSL, a global biotech company, experienced a significant drop after reporting a lower-than-expected profit forecast for FY24 due to challenges in its plasma collection business, though its long-term outlook remains positive. Cochlear, known for its hearing implants, saw its shares decline after a weak first-half result, but it is expected to recover with growth in the hearing implant market. Pro Medicus, a medical imaging technology firm, also faced a share price drop despite strong financial performance, attributed to concerns over future growth rates. The article suggests that while these companies face short-term issues, their strong fundamentals and market positions could make them attractive buys during this dip, especially for long-term investors looking at the healthcare sector's growth potential.

Read the Full marketindex Article at:
[ https://www.marketindex.com.au/news/should-you-buy-the-dip-on-asx-healthcare-stocks-csl-cochlear-and-pro-medicus ]